Author:
Godar Marie,Morello Virginia,Sadi Ava,Hultberg Anna,De Jonge Natalie,Basilico Cristina,Hanssens Valérie,Saunders Michael,Lambrecht Bart N.,El Khattabi Mohamed,de Haard Hans,Michieli Paolo,Blanchetot Christophe
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Fischer, N. et al. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG. Nature communications 6(6113), 1–12 (2015).
2. Frankel, S. R. & Baeuerle, P. A. Targeting T cells to tumor cells using bispecific antibodies. Current opinion in chemical biology 17(3), 385–392 (2013).
3. Bargou, R. et al. Tumor regression in cancer patients by very low doses of a T cell–engaging antibody. Science 321(5891), 974–977 (2008).
4. Portell, C. A., Wenzell, C. M. & Advani, A. S. Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia. Clinical pharmacology: advances and applications 5(Suppl 1), 5–11 (2013).
5. Seimetz, D., Lindhofer, H. & Bokemeyer, C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM× anti-CD3) as a targeted cancer immunotherapy. Cancer treatment reviews 36(6), 458–467 (2010).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献